Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article
- PMID: 24836658
- DOI: 10.3171/2014.1.SPINE13866
Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article
Abstract
Object: Intraspinal hemangioblastomas are relatively uncommon benign tumors. The surgical strategies remain controversial, and the risk factors with regard to clinical outcome are unclear. The purpose of this study was to analyze the clinical characteristics, imaging findings, surgical strategies, and functional outcomes associated with intraspinal hemangioblastomas.
Methods: A series of 92 patients who underwent 102 operations for resection of 116 intraspinal hemangioblastomas at a single institution during 2007-2011 were consecutively enrolled in this study. Of these, 60 patients (65.2%) had sporadic hemangioblastomas and 32 (34.8%) had von Hippel-Lindau disease. Preoperatively, 13 patients underwent digital subtraction angiography (DSA), 15 patients underwent 3D CT angiography (3D CTA), and none underwent preoperative embolization. Clinical characteristics, imaging findings, and operative records were analyzed. The advantages and disadvantages of DSA and 3D CTA were compared. For identification of risk factors that affect prognosis, logistic analysis was performed.
Results: The male/female patient ratio was 1.8:1.0 (59 male and 33 female patients). Of the tumors, 41% were intramedullary, 37% were intramedullary-extramedullary, and 22% were primarily extramedullary. Three-dimensional CTA and DSA did not differ significantly in the ability to identify the feeding arteries (p = 1.000) and image qualities (p = 0.367). However, compared with 3D CTA, the effective x-ray dose of spinal DSA was 2.73 times higher and the mean amount of contrast media injected was 1.88 times higher. Spinal DSA was more time consuming (mean 120 minutes) than 3D CTA (scanning time < 1 minute). No complications were observed after 3D CTA; acute paraparesis developed in 1 patient after DSA. Gross-total resection was achieved for 109 tumors (94.0%), and resection was subtotal for 7 tumors. Mean duration of follow-up was 50 months (range 24-78 months). At the most recent follow-up visit, the functional outcome was improved for 38 patients (41.3%), remained stable for 40 (43.5%), and deteriorated for 14 (15.2%). Logistic analysis showed that subtotal resection was a risk factor affecting prognosis (p = 0.003, OR 12.833, 95% CI 2.429-67.806).
Conclusions: The authors' study suggests that safe and effective treatment of intraspinal hemangioblastomas can be achieved for most patients, even without preoperative embolization. Gross-total resection, when safe to perform, leads to better outcomes. Compared with spinal DSA, 3D CTA is a promising technique because it is noninvasive, takes less time to perform, requires lower x-ray doses and less contrast media, results in fewer complications, and offers high accuracy for delineating the feeding arteries.
Keywords: 3D CTA = 3D CT angiography; DLP = dose length product; DSA = digital subtraction angiography; DSP = dose surface product; VHL = von Hippel-Lindau disease; hemangioblastoma; microsurgery; oncology; spinal; von Hippel-Lindau disease.
Similar articles
-
Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease.J Neurosurg Spine. 2010 Mar;12(3):233-42. doi: 10.3171/2009.10.SPINE09592. J Neurosurg Spine. 2010. PMID: 20192620
-
Spinal cord hemangioblastomas: significance of intraoperative neurophysiological monitoring for resection and long-term outcome.J Neurosurg Spine. 2017 Apr;26(4):483-493. doi: 10.3171/2016.8.SPINE16595. Epub 2016 Dec 16. J Neurosurg Spine. 2017. PMID: 27982764
-
Metastases to hemangioblastomas in von Hippel-Lindau disease.J Neurosurg. 2006 Aug;105(2):256-63. doi: 10.3171/jns.2006.105.2.256. J Neurosurg. 2006. PMID: 17219831
-
Imaging diagnosis and the role of endovascular embolization treatment for vascular intraspinal tumors.Neurosurg Focus. 2015 Aug;39(2):E16. doi: 10.3171/2015.5.FOCUS1514. Neurosurg Focus. 2015. PMID: 26235014 Review.
-
Primary Intradural Extramedullary Sporadic Spinal Hemangioblastomas: Case Report and Systematic Review.World Neurosurg. 2021 Aug;152:84-94. doi: 10.1016/j.wneu.2021.05.105. Epub 2021 Jun 1. World Neurosurg. 2021. PMID: 34087464
Cited by
-
Surgical Treatment of Intramedullary Hemangioblastomas: Current State of Problem (Review).Sovrem Tekhnologii Med. 2021;13(5):83-94. doi: 10.17691/stm2021.13.5.10. Epub 2021 Oct 29. Sovrem Tekhnologii Med. 2021. PMID: 35265353 Free PMC article. Review.
-
En Bloc Resection for Spinal Cord Hemangioblastomas: Surgical Technique and Clinical Outcomes.J Neurol Surg A Cent Eur Neurosurg. 2024 Nov;85(6):577-584. doi: 10.1055/s-0043-1776707. Epub 2023 Nov 22. J Neurol Surg A Cent Eur Neurosurg. 2024. PMID: 37992732 Free PMC article.
-
Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder.Front Psychiatry. 2021 Sep 3;12:684445. doi: 10.3389/fpsyt.2021.684445. eCollection 2021. Front Psychiatry. 2021. PMID: 34539458 Free PMC article.
-
Hydrocephalus: a rare initial manifestation of sporadic intramedullary hemangioblastoma : Intramedullary hemangioblastoma presenting as hydrocephalus.Childs Nerv Syst. 2017 Aug;33(8):1399-1403. doi: 10.1007/s00381-017-3415-0. Epub 2017 Apr 25. Childs Nerv Syst. 2017. PMID: 28444460
-
Comparison of the Recurrence and Surgical Outcome of Spinal Hemangioblastoma in Sporadic and Von Hippel-Lindau Diseases: A Subanalysis of a Nationwide Study by the Neurospinal Society of Japan.Neurospine. 2023 Sep;20(3):756-765. doi: 10.14245/ns.2346368.184. Epub 2023 Jun 20. Neurospine. 2023. PMID: 37350167 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous